Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.
Completed · Phase 2
Conditions studied: Alcoholism
In brief
Test the hypothesis that increasing doses of CP-866,087 will decrease the total number of drinks consumed during a 2 hour acute alcohol consumption assessment and to determine the safety and tolerability of multiple doses of CP-866,087 in alcohol dependent subjects compared to placebo.
Key facts
- Study ID
- NCT00147576
- Run by
- Pfizer
- People needed
- 88
- Starts
- 2003-12-01
- Expected to finish
- 2004-12-01
- Last updated by the study team
- 2012-10-02
Who can join
Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject meets the DSM-IV criterion for current alcohol dependence.
- Subject is currently not engaged in, and does not want, treatment for alcohol related problems.
You may not qualify if…
- Subject meets criteria for current DSM-IV diagnosis for any other psychoactive substance abuse or dependence disorder, excluding nicotine and caffeine.
- Specialized inpatient or outpatient alcoholism or other addiction treatment (except nicotine) within the past 12 months.
Where it is running
- Pfizer Investigational Site — Cerritos, California, United States
- Pfizer Investigational Site — New Haven, Connecticut, United States
- Pfizer Investigational Site — New Haven, Connecticut, United States
- Pfizer Investigational Site — Washington D.C., District of Columbia, United States
- Pfizer Investigational Site — Melbourne, Florida, United States
- Pfizer Investigational Site — Melbourne, Florida, United States
- Pfizer Investigational Site — Lenexa, Kansas, United States
- Pfizer Investigational Site — Providence, Rhode Island, United States
- Pfizer Investigational Site — Charleston, South Carolina, United States
- Pfizer Investigational Site — San Antonio, Texas, United States
- Pfizer Investigational Site — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.